Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance

AIMS/INTRODUCTION: Recently, dipeptidyl peptidase‐4 (DPP‐4) inhibitors have become available in Japan. It has not yet been clarified what clinical parameters could discriminate DPP‐4 inhibitor‐effective patients from DPP‐4 inhibitor‐ineffective patients. MATERIALS AND METHODS: We reviewed 33 consecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozawa, Junji, Kitamura, Tetsuhiro, Nishizawa, Hitoshi, Yasuda, Tetsuyuki, Maeda, Norikazu, Otsuki, Michio, Okita, Kohei, Iwahashi, Hiromi, Kaneto, Hideaki, Funahashi, Tohru, Imagawa, Akihisa, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019274/
https://www.ncbi.nlm.nih.gov/pubmed/24843651
http://dx.doi.org/10.1111/jdi.12016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019274/
https://www.ncbi.nlm.nih.gov/pubmed/24843651
http://dx.doi.org/10.1111/jdi.12016

Ejemplares similares